Effects of fingolimod, a sphingosine-1-phosphate (S1P) receptor agonist, on white matter microstructure, cognition and symptoms in schizophrenia

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

Stanley R. Kay, Abraham Fiszbein, Lewis A. Opler · Schizophrenia Bulletin · 1987 · 21.4K citations · Full text

Social Sciences, Psychiatry, Psychology +17

Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data

Stephen M. Smith, Mark Jenkinson, Heidi Johansen‐Berg et al. · NeuroImage · 2006 · 6.6K citations

Computing, Biostatistics, Neuroscience +14

Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference

Stephen M. Smith, Thomas E. Nichols · NeuroImage · 2008 · 5.6K citations

Computing, Computer Science, Computer Vision +10

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor et al. · New England Journal of Medicine · 2010 · 2.6K citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

White matter integrity, fiber count, and other fallacies: The do's and don'ts of diffusion MRI

Derek K. Jones, Thomas R. Knösche, Robert Turner · NeuroImage · 2012 · 2.4K citations

Medicine, Neuroscience, Radiology +17